Mach N - Search Results

1

Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.

Lathuilière A, Mach N, Schneider BL. Lathuilière A, et al. Among authors: mach n. Int J Mol Sci. 2015 May 8;16(5):10578-600. doi: 10.3390/ijms160510578. Int J Mol Sci. 2015. PMID: 26006227 Free PMC article. Review.

2

Cell encapsulation technology as a novel strategy for human anti-tumor immunotherapy.

Schwenter F, Zarei S, Luy P, Padrun V, Bouche N, Lee JS, Mulligan RC, Morel P, Mach N. Schwenter F, et al. Among authors: mach n. Cancer Gene Ther. 2011 Aug;18(8):553-62. doi: 10.1038/cgt.2011.22. Epub 2011 May 13. Cancer Gene Ther. 2011. PMID: 21566667

3

Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology.

Lathuiliere A, Vernet R, Charrier E, Urwyler M, Von Rohr O, Belkouch MC, Saingier V, Bouvarel T, Guillarme D, Engel A, Salmon P, Laumonier T, Grogg J, Mach N. Lathuiliere A, et al. Among authors: mach n. Mol Ther Methods Clin Dev. 2022 Aug 1;26:441-458. doi: 10.1016/j.omtm.2022.07.017. eCollection 2022 Sep 8. Mol Ther Methods Clin Dev. 2022. PMID: 36092361 Free PMC article.

4

Role of GM-CSF signaling in cell-based tumor immunization.

Zarei S, Schwenter F, Luy P, Aurrand-Lions M, Morel P, Kopf M, Dranoff G, Mach N. Zarei S, et al. Among authors: mach n. Blood. 2009 Jun 25;113(26):6658-68. doi: 10.1182/blood-2008-06-161075. Epub 2009 Mar 12. Blood. 2009. PMID: 19282460 Free PMC article.

5

Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model.

Vernet R, Charrier E, Cosset E, Fièvre S, Tomasello U, Grogg J, Mach N. Vernet R, et al. Among authors: mach n. Vaccines (Basel). 2021 May 10;9(5):484. doi: 10.3390/vaccines9050484. Vaccines (Basel). 2021. PMID: 34068677 Free PMC article.

6

High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75.

Zhang W, Mese K, Schellhorn S, Bahlmann N, Mach N, Bunz O, Dhingra A, Hage E, Lafon ME, Wodrich H, Heim A, Ehrhardt A. Zhang W, et al. Among authors: mach n. Int J Mol Sci. 2020 Sep 2;21(17):6370. doi: 10.3390/ijms21176370. Int J Mol Sci. 2020. PMID: 32887347 Free PMC article.

7

Cytokine-secreting tumor cell vaccines.

Mach N, Dranoff G. Mach N, et al. Curr Opin Immunol. 2000 Oct;12(5):571-5. doi: 10.1016/s0952-7915(00)00144-8. Curr Opin Immunol. 2000. PMID: 11007361 Review.

8

Giant Cell Tumor of Bone With Pseudosarcomatous Changes Leading to Premature Denosumab Therapy Interruption: A Case Report With Review of the Literature.

Sanchez-Pareja A, Larousserie F, Boudabbous S, Beaulieu JY, Mach N, Saiji E, Rougemont AL. Sanchez-Pareja A, et al. Among authors: mach n. Int J Surg Pathol. 2016 Jun;24(4):366-72. doi: 10.1177/1066896916629546. Epub 2016 Feb 3. Int J Surg Pathol. 2016. PMID: 26842345 Review.

9

First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies.

Migliorini D, Mach N, Aguiar D, Vernet R, Landis BN, Becker M, McKee T, Dutoit V, Dietrich PY. Migliorini D, et al. Among authors: mach n. Oncoimmunology. 2017 Jun 21;6(8):e1338235. doi: 10.1080/2162402X.2017.1338235. eCollection 2017. Oncoimmunology. 2017. PMID: 28919999 Free PMC article.

10

A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein.

Vernet R, Charrier E, Grogg J, Mach N. Vernet R, et al. Among authors: mach n. Vaccines (Basel). 2021 Jul 9;9(7):770. doi: 10.3390/vaccines9070770. Vaccines (Basel). 2021. PMID: 34358186 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

150 results

Search Page